Coverart for item
The Resource Antithrombotic drug therapy in cardiovascular disease, edited by Arman T. Askari, A. Michael Lincoff, (electronic book)

Antithrombotic drug therapy in cardiovascular disease, edited by Arman T. Askari, A. Michael Lincoff, (electronic book)

Label
Antithrombotic drug therapy in cardiovascular disease
Title
Antithrombotic drug therapy in cardiovascular disease
Statement of responsibility
edited by Arman T. Askari, A. Michael Lincoff
Contributor
Subject
Language
eng
Member of
Cataloging source
GW5XE
Dewey number
615.718
Illustrations
illustrations
Index
index present
LC call number
RC671.5
Literary form
non fiction
Nature of contents
  • dictionaries
  • bibliography
http://library.link/vocab/relatedWorkOrContributorName
  • Askari, Arman T
  • Lincoff, A. Michael
Series statement
Contemporary cardiology Totowa, N.J. : Unnumbered
http://library.link/vocab/subjectName
  • Fibrinolytic agents
  • Cardiovascular system
  • Cardiovascular Diseases
  • Fibrinolytic Agents
  • Thrombolytic Therapy
  • Thrombosis
  • Medicine
  • Pharmacy
Label
Antithrombotic drug therapy in cardiovascular disease, edited by Arman T. Askari, A. Michael Lincoff, (electronic book)
Instantiates
Publication
Bibliography note
Includes bibliographical references and index
Color
multicolored
Contents
Basic principles -- Platelets in arterial thrombosis -- Role of coagulation in arterial and venous thrombosis -- Link between inflammation and thrombosis -- Genetics of thrombosis -- Antithrombotic therapy for stable coronary atherosclerotic disease -- Aspirin in primary and secondary prevention of cardiovascular disease -- Thienopyridines in stable coronary disease -- Antithrombotic therapy for NSTE ACS -- Antiplatelet therapies in unstable angina and non-ST segment elevation myocardial infarction -- Unfractionated heparin and enoxaparin for the management of non-ST-segment elevation acute coronary syndromes -- Direct thrombin inhibitors in acute coronary syndromes -- Synthetic factors Xa inhibition in acute coronary syndromes -- Antithrombotic therapy for STEMI -- Antiplatelet therapies: aspirin, clopidogrel and thienopyridines, and glycoprotein IIb/IIIa inhibitors for the management of ST-segment elevation myocardial infarction -- Antithrombin therapy for acute ST-segment elevation myocardial infarction -- Fibrinolysis and facilitated PCI -- Antithrombotic therapy in interventional cardiology -- Antithrombotic therapy in percutaneous coronary intervention -- Antithrombotic therapy in carotid and peripheral intervention -- Monitoring of antithrombotic therapies in interventional cardiology -- Antithrombotic therapy in venous thromboembolism -- Venous thromboembolism -- Fibrinolysis for pulmonary embolism -- Duration of anticoagulant therapy after venous thromboembolism -- Clinical consideration -- Antithrombotic therapy for atrial fibrillation and cardioversion -- Antithrombotic therapy for valvular heart disease -- Antithrombotic therapy in heart failure and cardiomyopathy -- Heparin-induced thrombocytopenia -- Resistance to antiplatelet drugs
Control code
SPR663096543
Dimensions
unknown
Extent
1 online resource (xiii, 475 p.)
Form of item
online
Isbn
9786612828171
Other physical details
ill. (some col.)
Specific material designation
remote
Label
Antithrombotic drug therapy in cardiovascular disease, edited by Arman T. Askari, A. Michael Lincoff, (electronic book)
Publication
Bibliography note
Includes bibliographical references and index
Color
multicolored
Contents
Basic principles -- Platelets in arterial thrombosis -- Role of coagulation in arterial and venous thrombosis -- Link between inflammation and thrombosis -- Genetics of thrombosis -- Antithrombotic therapy for stable coronary atherosclerotic disease -- Aspirin in primary and secondary prevention of cardiovascular disease -- Thienopyridines in stable coronary disease -- Antithrombotic therapy for NSTE ACS -- Antiplatelet therapies in unstable angina and non-ST segment elevation myocardial infarction -- Unfractionated heparin and enoxaparin for the management of non-ST-segment elevation acute coronary syndromes -- Direct thrombin inhibitors in acute coronary syndromes -- Synthetic factors Xa inhibition in acute coronary syndromes -- Antithrombotic therapy for STEMI -- Antiplatelet therapies: aspirin, clopidogrel and thienopyridines, and glycoprotein IIb/IIIa inhibitors for the management of ST-segment elevation myocardial infarction -- Antithrombin therapy for acute ST-segment elevation myocardial infarction -- Fibrinolysis and facilitated PCI -- Antithrombotic therapy in interventional cardiology -- Antithrombotic therapy in percutaneous coronary intervention -- Antithrombotic therapy in carotid and peripheral intervention -- Monitoring of antithrombotic therapies in interventional cardiology -- Antithrombotic therapy in venous thromboembolism -- Venous thromboembolism -- Fibrinolysis for pulmonary embolism -- Duration of anticoagulant therapy after venous thromboembolism -- Clinical consideration -- Antithrombotic therapy for atrial fibrillation and cardioversion -- Antithrombotic therapy for valvular heart disease -- Antithrombotic therapy in heart failure and cardiomyopathy -- Heparin-induced thrombocytopenia -- Resistance to antiplatelet drugs
Control code
SPR663096543
Dimensions
unknown
Extent
1 online resource (xiii, 475 p.)
Form of item
online
Isbn
9786612828171
Other physical details
ill. (some col.)
Specific material designation
remote

Library Locations

Processing Feedback ...